Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


02.07.2018

4 Am J Cardiol
2 Am J Emerg Med
1 Circulation
1 Clin Cardiol
1 Eur J Pharmacol
10 Int J Cardiol
2 J Am Coll Cardiol
1 J Cardiol
1 J Cardiovasc Electrophysiol
2 J Interv Card Electrophysiol
3 J Thromb Thrombolysis
9 Pacing Clin Electrophysiol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. GARCIA-GARCIA C, Oliveras T, Rueda F, Perez-Fernandez S, et al
    Primary Ventricular Fibrillation in the Primary Percutaneous Coronary Intervention ST-Segment Elevation Myocardial Infarction Era (from the "Codi IAM" Multicenter Registry).
    Am J Cardiol. 2018 Jun 27. pii: S0002-9149(18)31055.
    PubMed     Text format     Abstract available

  2. ERKUNER O, Dudink EAMP, Nieuwlaat R, Rienstra M, et al
    Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey).
    Am J Cardiol. 2018 May 11. pii: S0002-9149(18)31054.
    PubMed     Text format     Abstract available

  3. LUO X, Xiong Q, Xu J, Hong K, et al
    Differences in Heart Rate Response and Recovery After 6-Minute Walk Test Between Patients With Atrial Fibrillation and in Sinus Rhythm.
    Am J Cardiol. 2018 Jun 26. pii: S0002-9149(18)31049.
    PubMed     Text format     Abstract available

  4. INOUE YY, Ipek EG, Khurram IM, Ciuffo L, et al
    Relation of Electrocardiographic Left Atrial Abnormalities to Risk of Stroke in Patients with Atrial Fibrillation.
    Am J Cardiol. 2018 May 3. pii: S0002-9149(18)30863.
    PubMed     Text format     Abstract available


    Am J Emerg Med

  5. HIRSCHY R, Ackerbauer KA, Peksa GD, O'Donnell EP, et al
    Response by Hirschy et al. to letter regarding article, "Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction".
    Am J Emerg Med. 2018 Jun 19. pii: S0735-6757(18)30509.
    PubMed     Text format    

  6. MERT GO, Dural M, Mert KU
    Comparison of acute management of atrial fibrillation in heart failure with unequal sized groups.
    Am J Emerg Med. 2018 Jun 19. pii: S0735-6757(18)30510.
    PubMed     Text format    


    Circulation

  7. SIONTIS KC, Zhang X, Eckard A, Bhave N, et al
    Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States.
    Circulation. 2018 Jun 28. pii: CIRCULATIONAHA.118.035418.
    PubMed     Text format     Abstract available


    Clin Cardiol

  8. YOUNIS A, Shaviv E, Nof E, Israel A, et al
    The Role and Outcome of Cardiac Rehabilitation Program in Patients with Atrial Fibrillation.
    Clin Cardiol. 2018 Jun 23. doi: 10.1002/clc.23001.
    PubMed     Text format     Abstract available


    Eur J Pharmacol

  9. ZHANG D, Tu H, Wadman MC, Li YL, et al
    Substrates and potential therapeutics of ventricular arrhythmias in heart failure.
    Eur J Pharmacol. 2018 Jun 22. pii: S0014-2999(18)30357.
    PubMed     Text format     Abstract available


    Int J Cardiol

  10. GOETTE A
    Uninterrupted NOAC therapy in patients undergoing catheter ablation of atrial fibrillation: "Dual anticoagulant therapy" ready for primetime or systematic overtreatment?
    Int J Cardiol. 2018 Jun 13. pii: S0167-5273(18)33663.
    PubMed     Text format    

  11. CONTE G, Soejima K, de Asmundis C, Chierchia GB, et al
    Value of high-resolution mapping in optimizing cryoballoon ablation of atrial fibrillation.
    Int J Cardiol. 2018 Jun 1. pii: S0167-5273(18)30713.
    PubMed     Text format     Abstract available

  12. ANDERSSON NW, Svanstrom H, Lund M, Pasternak B, et al
    Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Jun 19. pii: S0167-5273(17)35612.
    PubMed     Text format     Abstract available

  13. TRAN HV, Erskine NA, Nguyen HL, McManus DD, et al
    Increase in white blood cell count is associated with the development of atrial fibrillation after an acute coronary syndrome.
    Int J Cardiol. 2018 Jun 5. pii: S0167-5273(17)37883.
    PubMed     Text format     Abstract available

  14. TOSO E, Peyracchia M, Matta M, D'Ascenzo F, et al
    Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
    Int J Cardiol. 2018 Jun 19. pii: S0167-5273(18)30865.
    PubMed     Text format     Abstract available

  15. SVINGEN GFT, Zuo H, Ueland PM, Seifert R, et al
    Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation.
    Int J Cardiol. 2018;267:100-106.
    PubMed     Text format     Abstract available

  16. FENDER AC, Dobrev D
    Switching off the jitters: Dabigatran as a candidate approach to halt atrial fibrillation?
    Int J Cardiol. 2018 Jun 13. pii: S0167-5273(18)33661.
    PubMed     Text format    

  17. AYABE K, Goto S
    High rate of death in patients with atrial fibrillation -Results from EORP-AF Pilot General Registry.
    Int J Cardiol. 2018 Jun 22. pii: S0167-5273(18)33076.
    PubMed     Text format    

  18. BOERSMA LVA
    Optimizing S-ICD implant technique: No pain, the true gain?
    Int J Cardiol. 2018;258:159-160.
    PubMed     Text format    

  19. SANTORO F, Stiermaier T, Tarantino N, Guastafierro F, et al
    Diagnostic criteria, left ventricular thrombosis, and QT-interval in Takotsubo syndrome.
    Int J Cardiol. 2018;258:29.
    PubMed     Text format    


    J Am Coll Cardiol

  20. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed.
    J Am Coll Cardiol. 2018;72:125-126.
    PubMed     Text format    

  21. LEE CJ, Gerds TA, Carlson N, Bonde AN, et al
    Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:17-26.
    PubMed     Text format     Abstract available


    J Cardiol

  22. ITO M, Yamabe H, Koyama J, Kanazawa H, et al
    Analysis for the primary predictive factor for the incidence of esophageal injury after ablation of atrial fibrillation.
    J Cardiol. 2018 Jun 20. pii: S0914-5087(18)30144.
    PubMed     Text format     Abstract available


    J Cardiovasc Electrophysiol

  23. FUKAYA H, Nishinarita R, Igarashi G, Ako J, et al
    Intra-isthmus atrial flutter visualized with ultra-high resolution mapping.
    J Cardiovasc Electrophysiol. 2018 Jun 28. doi: 10.1111/jce.13688.
    PubMed     Text format    


    J Interv Card Electrophysiol

  24. REINSCH N, Buchholz J, Ruprecht U, Neven K, et al
    Entrapment of a circular mapping catheter in a pulmonary vein during atrial fibrillation ablation.
    J Interv Card Electrophysiol. 2018 Jun 29. pii: 10.1007/s10840-018-0401.
    PubMed     Text format    

  25. COUTINO HE, Abugattas JP, Sieira J, Salghetti F, et al
    Single 3-min freeze per vein ablation strategy with the second-generation cryoballoon for atrial fibrillation in a large cohort of patients: long term outcome after a single procedure.
    J Interv Card Electrophysiol. 2018 Jun 13. pii: 10.1007/s10840-018-0393.
    PubMed     Text format     Abstract available


    J Thromb Thrombolysis

  26. CHI G, Yee MK, Kalayci A, Kerneis M, et al
    Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.
    J Thromb Thrombolysis. 2018 Jun 26. pii: 10.1007/s11239-018-1703.
    PubMed     Text format     Abstract available

  27. HUGHEY AB, Gu X, Haymart B, Kline-Rogers E, et al
    Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the "Real-World" Michigan Anticoagulation Quality Improvement Initiative (MAQI(2)) registry to the RE-LY, ROCKET-AF, and ARISTOTLE
    J Thromb Thrombolysis. 2018 Jun 14. pii: 10.1007/s11239-018-1698.
    PubMed     Text format     Abstract available

  28. KHEIRI B, Haykal T, Abdalla A, Osman M, et al
    Non-vitamin K antagonist oral anticoagulants in cardioversion of atrial fibrillation: a network meta-analysis.
    J Thromb Thrombolysis. 2018 Jun 15. pii: 10.1007/s11239-018-1694.
    PubMed     Text format    


    Pacing Clin Electrophysiol

  29. ANVARI S, Akbarzadeh MA, Bayat F, Namazi MH, et al
    Left Ventricular Sphericity Index Analysis for the Prediction of Appropriate Implantable Cardioverter-Defibrillator Therapy.
    Pacing Clin Electrophysiol. 2018 Jun 21. doi: 10.1111/pace.13420.
    PubMed     Text format     Abstract available

  30. FRYDENSBERG VS, Skovbakke SJ, Pedersen SS, Kok RN, et al
    Body image concerns in patients with an implantable cardioverter defibrillator: A scoping review.
    Pacing Clin Electrophysiol. 2018 Jun 22. doi: 10.1111/pace.13421.
    PubMed     Text format     Abstract available

  31. VOSKOBOINIK A, Wong MCG, Elliott JK, Costello BT, et al
    Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and non-ischemic cardiomyopathy.
    Pacing Clin Electrophysiol. 2018 Jun 22. doi: 10.1111/pace.13426.
    PubMed     Text format     Abstract available

  32. WALI E, Deshmukh A, Bukari A, Broman M, et al
    Impact of high-grade Atrioventricular block and cumulative frequent pacing on atrial arrhythmias.
    Pacing Clin Electrophysiol. 2018 Jun 21. doi: 10.1111/pace.13425.
    PubMed     Text format     Abstract available

  33. SANTANGELI P, Lin D
    Reaching for the summit: The dark side of ablating ventricular arrhythmias from within the coronary venous system.
    Pacing Clin Electrophysiol. 2018 Jun 23. doi: 10.1111/pace.13428.
    PubMed     Text format    

  34. CANDEMIR B, Ozyurek E, Vurgun K, Turan N, et al
    Effect of radiofrequency on epicardial myocardium after ablation of ventricular arrhythmias from within coronary sinus.
    Pacing Clin Electrophysiol. 2018 Jun 23. doi: 10.1111/pace.13429.
    PubMed     Text format     Abstract available

  35. JOHNSON AE, Adhikari S, Althouse AD, Thoma F, et al
    Persistent sex disparities in implantable cardioverter-defibrillator therapy.
    Pacing Clin Electrophysiol. 2018 Jun 30. doi: 10.1111/pace.13435.
    PubMed     Text format     Abstract available

  36. CHEN L, Du X, Dong J, Ma CS, et al
    Performance and validation of a simplified postoperative atrial fibrillation risk score.
    Pacing Clin Electrophysiol. 2018 Jun 30. doi: 10.1111/pace.13434.
    PubMed     Text format     Abstract available

  37. CAY S, Ozeke O, Ozcan F, Aras D, et al
    Left posterior fascicular ventricular tachycardia: Ablative strategies.
    Pacing Clin Electrophysiol. 2018;41:99.
    PubMed     Text format    


    PLoS One

  38. CHARLTON B, Adeboyeje G, Barron JJ, Grady D, et al
    Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban.
    PLoS One. 2018;13:e0193912.
    PubMed     Text format     Abstract available

  39. VAN MIERT JHA, Bos S, Veeger NJGM, Meijer K, et al
    Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis.
    PLoS One. 2018;13:e0194208.
    PubMed     Text format     Abstract available

  40. LING X, Zhou H, Ni Y, Wu C, et al
    Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials.
    PLoS One. 2018;13:e0193303.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: